Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin A Nephropathy”

410 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 410 results

Early research (Phase 1)Study completedNCT02216890
What this trial is testing

Safety Study of SGN-CD70A in Cancer Patients

Who this might be right for
Renal Cell CarcinomaMantle-Cell LymphomaDiffuse, Large B-Cell, Lymphoma+1 more
Seagen Inc. 38
Not applicableStudy completedNCT04741386
What this trial is testing

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study

Who this might be right for
Covid19Chronic Kidney Diseases
University Medical Center Groningen 854
Large-scale testing (Phase 3)Not Yet RecruitingNCT07642050
What this trial is testing

Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Biohaven Therapeutics Ltd. 420
Not applicableStudy completedNCT00006137
What this trial is testing

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 43
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT04626505
What this trial is testing

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.

Who this might be right for
Chronic Kidney DiseaseInflammationCardiovascular Risk
Novo Nordisk A/S 36
Testing effectiveness (Phase 2)Study completedNCT05983770
What this trial is testing

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 127
Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Large-scale testing (Phase 3)Study completedNCT00657059
What this trial is testing

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 151
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Testing effectiveness (Phase 2)UnknownNCT03633864
What this trial is testing

Fecal Microbiota Transplantation for Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Air Force Military Medical University, China 30
Not applicableLooking for participantsNCT01802034
What this trial is testing

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Who this might be right for
Kidney DiseasesKidney Failure, ChronicDiabetic Nephropathy+2 more
The Rogosin Institute 2,000
Not applicableStudy completedNCT07607002
What this trial is testing

Assessing the Global Burden of IgA Nephropathy (IgAN) in Patients Receiving Hemodialysis: A Real-World Study Using DOPPS Data

Who this might be right for
IgAN - IgA Nephropathy
Arbor Research Collaborative for Health 70,000
Testing effectiveness (Phase 2)Ended earlyNCT05125068
What this trial is testing

Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA NephropathyIgAN
Eledon Pharmaceuticals 24
Early research (Phase 1)Study completedNCT04342325
What this trial is testing

The Clinical Trial of ADR-001 for IgA Nephropathy

Who this might be right for
Glomerulonephritis , IGA
Nagoya University 9
Post-approval studies (Phase 4)Study completedNCT00498368
What this trial is testing

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Mayo Clinic 34
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Post-approval studies (Phase 4)UnknownNCT03218852
What this trial is testing

Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 133
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Load More Results